Addition of I.V. Citicoline to Standard of Care in Hospitalized COVID Patients with Acute Hypoxemic Respiratory Failure or ARDS: A Block-Randomized, Double-Blinded, Placebo-Controlled, Phase 1/2 Superiority TrialIan C. Davis, Elliott D. Crouser, Joshua A. Englert et al.|SSRN Electronic Journal|2025Cited by 0